The offering totals $40,000,000 at the public offering price, with $37,600,000 to Teknova before expenses. Underwriters have a 30-day option to buy up to 1,200,000 more shares.
Latest Alpha Teknova news
We have not published a story on Alpha Teknova yet. When there is news, it will appear here.
Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $6.0 million, plus short-term investments of $11.4 million, $17.4 million in all.
Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.
Questions about Alpha Teknova
Has Alpha Teknova raised money recently?
Our latest story on this, dated Oct 20, 2026: "Alpha Teknova launches stock offering, then prices 8,000,000 shares at $5.00". The story links the filing or release it is based on. Read the story.
What is the ticker symbol of Alpha Teknova?
Alpha Teknova, Inc. trades under the ticker TKNO on NASDAQ.
Where is Alpha Teknova listed?
Alpha Teknova, Inc. is listed on NASDAQ.
What is the SEC CIK of Alpha Teknova?
The SEC Central Index Key (CIK) for Alpha Teknova, Inc. is 1850902. Its filings are on SEC EDGAR.
How many shares does Alpha Teknova have outstanding?
53,688,246 shares as of 2026-08-05, per the cover page of its 10-Q filed 2026-08-06.
Which country or territory is Alpha Teknova listed under?
Our directory records Alpha Teknova, Inc. under United States.
What does Alpha Teknova do?
Our directory classifies Alpha Teknova, Inc. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.
What is the ISIN of Alpha Teknova?
The ISIN recorded for Alpha Teknova, Inc. is US02080L1026.
Does aibio.space cover Alpha Teknova?
aibio.space lists Alpha Teknova, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.
Where is Alpha Teknova incorporated?
SEC records list its state or country of incorporation as DE.
What was Alpha Teknova's revenue last year?
$40.5 million for the fiscal year ended Dec 31, 2025, as reported to the SEC.
Is Alpha Teknova profitable?
Alpha Teknova, Inc. reported a net loss of $17.3 million for the fiscal year ended Dec 31, 2025, and used $8.6 million of cash in operations, per its annual report to the SEC.
How much does Alpha Teknova spend on research and development?
$2.2 million in the fiscal year ended Dec 31, 2025, per its annual report.
How much cash does Alpha Teknova have?
$17.4 million in cash and short-term investments at Jun 30, 2026, per its 10-Q.
What is the latest Alpha Teknova (TKNO) stock news?
Our latest story on Alpha Teknova, dated Oct 20, 2026: "Alpha Teknova launches stock offering, then prices 8,000,000 shares at $5.00". The offering totals $40,000,000 at the public offering price, with $37,600,000 to Teknova before expenses. Underwriters have a 30-day option to buy up to 1,200,000 more shares. Source.
Investor discussion: Alpha Teknova
Members talk about Alpha Teknova (TKNO). Reader posts, not aibio.space reporting, and not investment advice.
Rules
Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.
Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.
Capital-markets timeline
Financings, listing notices, splits, legal actions and other investor events at Alpha Teknova, newest first. Each line links the filing it comes from.
Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NASDAQ:TKNO on TradingView.
SEC filings and registration
SEC name
Alpha Teknova, Inc.
CIK
1850902
Industry (SIC)
In Vitro & In Vivo Diagnostic Substances (2835)
US tickers
TKNO (Nasdaq)
State or country of incorporation
DE
Fiscal year ends
December 31
Filer category
<br>Emerging growth company
Business address
2451 BERT DRIVE, HOLLISTER, CA, 95023
Phone
8316371100
Shares outstanding
53,688,246 as of 2026-08-05 (10-Q filed 2026-08-06)
Recent filings (8-K and 6-K are the company's own announcements)
Source: SEC EDGAR, retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices.
Listing details
Alpha Teknova, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker TKNO, recorded under United States. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.
Published and maintained by aibio.space. Not investment advice. How we work.
Who manages this pageThis page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio